First Business Financial Services’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-2,964
Closed -$206K 189
2025
Q1
$206K Hold
2,964
0.02% 165
2024
Q4
$255K Hold
2,964
0.03% 151
2024
Q3
$353K Buy
2,964
+30
+1% +$4K 0.04% 125
2024
Q2
$419K Hold
2,934
0.04% 113
2024
Q1
$377K Sell
2,934
-148
-5% -$17.6K 0.04% 124
2023
Q4
$319K Buy
+3,082
New +$305K 0.04% 126

Other funds holding NVO

First Business Financial Services's NVO Position: Q2 2025 in Review

First Business Financial Services sold out of Novo Nordisk (NVO) in Q2 2025, closing a stake of 2,964 shares — an estimated $206K sold.

First Business Financial Services first reported a position in NVO in Q4 2023 and held it in 6 quarters. The position peaked at $419K in Q2 2024. 1,481 funds tracked by Wall St. Rank hold NVO as of Q2 2025.

  • First Business Financial Services reported no remaining Novo Nordisk position as of Q2 2025 after selling out during the quarter.
  • First Business Financial Services sold 2,964 Novo Nordisk shares in Q2 2025, an estimated $206K.
  • First Business Financial Services first reported a position in Novo Nordisk in Q4 2023 and held it in 6 quarters.
  • First Business Financial Services's Novo Nordisk position peaked at $419K in Q2 2024.
  • 1,481 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2025.

Based on First Business Financial Services's 13F filing for Q2 2025, filed 31 Jul 2025.